BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25311867)

  • 21. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS.
    Fan Q; Hu X; Zhang H; Wang S; Zhang H; You C; Zhang CY; Liang H; Chen X; Ba Y
    Cell Physiol Biochem; 2017; 44(4):1311-1324. PubMed ID: 29183007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown long noncoding RNA nuclear paraspeckle assembly transcript 1 suppresses colorectal cancer through modulating miR-193a-3p/KRAS.
    Zhu Z; Du S; Yin K; Ai S; Yu M; Liu Y; Shen Y; Liu M; Jiao R; Chen X; Guan W
    Cancer Med; 2019 Jan; 8(1):261-275. PubMed ID: 30575330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2.
    Wang H; Zhao F; Cai S; Pu Y
    J Bone Oncol; 2019 Aug; 17():100241. PubMed ID: 31193934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.
    Liang H; Liu M; Yan X; Zhou Y; Wang W; Wang X; Fu Z; Wang N; Zhang S; Wang Y; Zen K; Zhang CY; Hou D; Li J; Chen X
    J Biol Chem; 2015 Jan; 290(2):926-40. PubMed ID: 25391651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.
    Kwon JE; Kim BY; Kwak SY; Bae IH; Han YH
    Apoptosis; 2013 Jul; 18(7):896-909. PubMed ID: 23546867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
    Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
    Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
    Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.
    Wu G; Guo Z; Chang X; Kim MS; Nagpal JK; Liu J; Maki JM; Kivirikko KI; Ethier SP; Trink B; Sidransky D
    Cancer Res; 2007 May; 67(9):4123-9. PubMed ID: 17456585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
    Hiraide S; Takahashi M; Yoshida Y; Yamada H; Komine K; Ishioka C
    Cancer Sci; 2021 Sep; 112(9):3856-3870. PubMed ID: 34288281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
    Liu P; Li X; Guo X; Chen J; Li C; Chen M; Liu L; Zhang X; Zu X
    Cell Prolif; 2019 Jul; 52(4):e12614. PubMed ID: 30983072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis.
    Wu D; Nie X; Ma C; Liu X; Liang X; An Y; Zhao B; Wu X
    Biomed Pharmacother; 2017 Nov; 95():207-214. PubMed ID: 28843909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway.
    Wang B; Wang K; Jin T; Xu Q; He Y; Cui B; Wang Y
    Biomed Pharmacother; 2020 Sep; 129():110395. PubMed ID: 32887025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
    Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
    J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.